Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.84
Delayed Data
As of Feb 05
 -0.05 / -2.65%
Today’s Change
1.39
Today|||52-Week Range
9.37
+6.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues23.0M4.4M5.2M10.0M
 
 
 
 
 
Depreciation And Amortization52.0K51.0K52.0K54.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.5M19.8M25.9M20.9M
 
 
 
 
 
Research And Development13.0M11.2M15.1M8.8M
 
 
 
 
 
Total Operating Expenses20.6M19.8M25.9M20.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.4M-15.5M-20.7M-10.9M
 
 
 
 
 
Interest Expense On Debt1.8M1.8M1.8M1.9M
 
 
 
 
 
Other Expenses0.000.000.001.6M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income607.0K-17.2M-22.5M-11.1M
 
 
 
 
 
Net Income607.0K-17.2M-22.5M-11.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS123.0M123.9M125.2M129.7M
 
 
 
 
 
Shares To Calculate EPS Diluted123.0M123.9M125.2M129.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$0.14-$0.18-$0.09
 
 
 
 
EPS Diluted$0.00-$0.14-$0.18-$0.09